Home » Medical Devices » OTC Continuous Glucose Monitors Market

Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market By Product Type (Continuous Glucose Monitors, Smart Glucometers, Biosensors, Others); By Technology (Disposable Minimally Invasive Sensors (Wearable), Smart Device Integrated Systems (Mobile App Connectivity, Bluetooth)); By Consumer Type (Non-diabetic Health Enthusiasts, Pre-diabetic and At-risk Individuals, Diabetic Patients); By Application (Diabetes Management, Preventive Health and Wellness Monitoring, Fitness and Personalized Nutrition); By Distribution Channel (Pharmacies / Drugstores, Online Retailers, Supermarkets / Specialty Health Stores) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2024
Base Year	2024
Forecast Period	2025-2032
Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Size 2024	USD 328.17 Million
Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market, CAGR	15.35%
Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Size 2032	USD 1,111.05 Million

Market Overview:

The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market size was valued at USD 158.30 million in 2018 to USD 328.17 million in 2024 and is anticipated to reach USD 1,111.05 million by 2032, at a CAGR of 15.35% during the forecast period.

Key drivers fueling the OTC CGM market include the rising prevalence of diabetes and prediabetes, the increasing adoption of digital health tools, and ongoing innovations in sensor technology that deliver improved accuracy, comfort, and longer wear times. The market also benefits from heightened awareness about proactive health management and the integration of CGMs with mobile health applications, empowering patients to make informed decisions and improve glycemic control independently. Additionally, increased availability of OTC CGMs in retail pharmacies and online platforms is making these devices more accessible to a wider population.

Regionally, North America holds the dominant market share, underpinned by strong healthcare infrastructure and rapid adoption of consumer health technologies. Strategic collaborations between device manufacturers and retail pharmacy chains are further boosting product visibility and distribution in the region. Europe follows closely, driven by increasing diabetes incidence and supportive regulatory frameworks for non-prescription CGMs. The Asia-Pacific region is projected to witness the fastest growth, attributed to the expanding diabetic population, rising healthcare expenditure, and increasing acceptance of digital health solutions.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights:

The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market is expected to grow from USD 158.30 million in 2018 to USD 1,111.05 million by 2032, at a CAGR of 15.35%, driven by rising diabetes and prediabetes prevalence.
Innovations in sensor technology, improved accuracy, longer wear times, and non-invasive designs are enhancing product adoption and user comfort in the OTC CGM market.
Growing awareness and consumer empowerment in proactive health management are significantly boosting demand for OTC CGMs through educational campaigns and digital health initiatives.
The expansion of distribution channels, including retail pharmacies and online platforms, has increased OTC CGM accessibility and market penetration.
North America holds the largest share of the market, benefiting from advanced healthcare infrastructure and rapid adoption of digital health technologies.
The Asia Pacific region is experiencing the fastest growth, driven by the increasing diabetic population, rising healthcare spending, and expanding digital health solutions.
In Latin America, improved healthcare infrastructure, rising diabetes awareness, and expanded access to OTC CGMs through retail and online channels are driving market growth.

Market Drivers:

Rising Prevalence of Diabetes and Prediabetes Fuels Market Demand

The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market experiences significant growth due to the surging rates of diabetes and prediabetes worldwide. Health authorities report escalating incidences across both developed and developing regions, driving demand for convenient self-monitoring solutions. Patients require accessible tools to manage their conditions outside clinical settings, and OTC CGMs directly address this necessity. It provides real-time data and removes the barriers of prescription-only models, making continuous monitoring feasible for millions. This trend supports a larger movement toward self-managed healthcare. Stakeholders across the healthcare ecosystem recognize the impact of widespread diabetes, prioritizing solutions that improve daily glucose management.

For instance, the FDA approved the Dexcom Stelo Glucose Biosensor System in March 2024 as the first OTC CGM specifically for adults 18 and older with prediabetes or type 2 diabetes not using insulin, allowing direct purchase without a prescription.

Technological Advancements Drive Product Innovation and User Comfort

Ongoing advancements in biosensor technology, wireless connectivity, and device miniaturization support the expansion of the Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market. It now features sensors with higher accuracy, longer lifespans, and increased comfort for users, resulting in broader adoption. Developers focus on improving calibration-free technology and non-invasive designs, meeting consumer expectations for ease of use. Integration with smartphones and digital platforms enhances usability, providing seamless access to glucose data. These innovations make daily glucose management more efficient and less intrusive. The rapid pace of R&D ensures the market remains highly dynamic and competitive.

For instance, the Abbott Free Style Libre 2 CGM sensor is designed to deliver accurate glucose readings for up to 14 days of continuous wear.

Increasing Health Awareness and Patient Empowerment Shape Market Growth

Growing awareness about the importance of proactive diabetes management significantly influences the Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market. Educational campaigns and digital health initiatives inform consumers about the risks of uncontrolled blood sugar. People are more likely to seek real-time monitoring solutions to avoid complications and improve their quality of life. The market capitalizes on this shift, offering devices that empower users to make informed health decisions. It helps bridge the gap between routine care and clinical intervention. This heightened awareness translates to stronger product demand across all age groups.

Expanding Access Through Retail Pharmacies and Online Distribution Channels

The availability of OTC CGMs in retail pharmacies and e-commerce platforms increases accessibility and accelerates market penetration. Consumers can now purchase these devices directly, bypassing traditional healthcare channels. This model enhances convenience and allows greater reach, particularly in regions with limited healthcare infrastructure. The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market benefits from the rise of digital retail and pharmacy partnerships. It leverages widespread distribution networks to ensure timely product availability. Expanded access not only drives sales but also supports ongoing education about self-monitoring and disease prevention.

Market Trends:

Integration with Digital Health Ecosystems and Mobile Applications is Transforming User Experience

The integration of OTC continuous glucose monitors with digital health ecosystems and mobile applications is reshaping the landscape of diabetes management. Users now connect their CGM devices to smartphones and health platforms, enabling real-time tracking and seamless sharing of glucose data with healthcare providers or family members. It improves adherence to care plans and enhances personalized interventions. Remote monitoring capabilities foster stronger patient engagement and promote timely clinical decisions. Many devices now offer predictive alerts, data analytics, and actionable health insights through user-friendly interfaces. The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market responds to these trends by supporting greater connectivity, interactivity, and convenience for end-users.

For instance, the Dexcom Follow app allows users to share real-time glucose data with up to 10 people, improving care coordination and support structures.

Shift Toward Non-Invasive and Wearable Technologies is Expanding Market Reach

The market is witnessing a clear shift toward non-invasive, discreet, and wearable CGM technologies, driven by consumer demand for comfort and ease of use. Leading manufacturers prioritize thin, flexible sensors and patch-style monitors that reduce discomfort and encourage consistent usage. It addresses consumer preferences for minimal disruption to daily routines, supporting broad adoption across diverse age groups. Companies invest in research to improve sensor longevity, calibration-free designs, and waterproof features. These trends increase device accessibility for those managing diabetes and appeal to health-conscious individuals focused on preventive care. The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market evolves rapidly as innovation continues to blur the lines between medical devices and everyday wellness technology.

For instance, Abbott’s FreeStyle Libre portfolio incorporates a factory-calibrated sensor that allows for 14 consecutive days of wear, supporting longer continuous glucose measurement without routine calibrations.

Market Challenges Analysis:

Regulatory Hurdles and Product Reliability Concerns Hamper Market Growth

The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market faces significant challenges from complex regulatory pathways and evolving compliance requirements. Many markets enforce stringent standards for safety, accuracy, and data security. It must address concerns regarding product reliability and calibration errors, which can undermine user trust and adoption rates. Uncertainties in regulatory approval timelines can slow new product launches and hinder innovation. Ensuring devices meet diverse regional guidelines presents further complexity. Stakeholders must invest in ongoing quality assurance and transparency to maintain credibility and market access.

High Costs and Limited Awareness Restrict Wider Adoption

Despite recent advancements, high upfront costs and limited reimbursement policies restrict access for many consumers. It creates a barrier, especially in emerging economies and among underinsured populations. Some users remain unaware of the benefits and availability of OTC CGMs, reducing potential market penetration. Effective education and outreach programs are essential to expand understanding and drive demand. The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market requires strategies to address affordability and promote broader acceptance. Industry leaders must focus on cost optimization and awareness campaigns to support sustainable growth.

Market Opportunities:

Expansion into Untapped Emerging Markets Offers Strong Growth Potential

Expanding into emerging markets presents a significant growth opportunity for the Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market. Rapid urbanization, rising disposable incomes, and increasing rates of diabetes in countries across Asia-Pacific, Latin America, and Africa create fertile ground for adoption. It can leverage partnerships with local distributors and healthcare providers to enhance market penetration. Customized awareness campaigns and affordable product offerings will help address region-specific needs. Governments and NGOs increasingly prioritize diabetes prevention and management, further supporting market access. The ability to reach new demographics positions the market for robust long-term expansion.

Advancements in Product Innovation and Digital Integration Accelerate Market Growth

Continued investment in product innovation and digital integration creates compelling opportunities for the Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market. It can benefit from developing next-generation sensors, improved data analytics, and user-friendly mobile interfaces. Collaborations with technology firms and app developers will strengthen connectivity and enhance the user experience. The integration of artificial intelligence and machine learning holds promise for more personalized diabetes management. Emphasizing convenience, accuracy, and seamless data sharing will attract a broader user base. Strategic innovation supports the market’s evolution into a mainstream healthcare solution.

Market Segmentation Analysis:

By Product Type

The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market is segmented into continuous glucose monitors, smart glucometers, biosensors, and others. Continuous glucose monitors dominate this segment, valued for real-time glucose readings and actionable insights. Smart glucometers and biosensors follow, attracting tech-savvy users seeking connected, convenient solutions. It benefits from strong demand for biosensors, which support discreet and non-invasive glucose tracking.

For instance, Dexcom Stelo delivers continuous glucose monitoring for 15 days per sensor, available OTC since March 2024.

By Technology

Disposable minimally invasive sensors hold the largest market share, supported by advancements in accuracy, comfort, and extended wear time. Smart device integrated systems, featuring mobile app connectivity and Bluetooth, are rapidly gaining momentum. It appeals to consumers who value seamless data transfer and integration with broader digital health ecosystems.

By Consumer Type

Diabetic patients account for the largest share in this segment, reflecting the market’s focus on supporting chronic disease management. Pre-diabetic and at-risk individuals are increasingly adopting OTC CGMs to monitor glucose trends and enable early intervention. Non-diabetic health enthusiasts also represent a rising segment, interested in using these solutions for fitness, nutrition, and general wellness monitoring.

For instance, Medtronic’s Guardian Sensor 3 is FDA approved for use on the upper arm and is incorporated

Segmentations:

By Product Type

Continuous Glucose Monitors
Smart Glucometers
Biosensors
Others

By Technology

Disposable Minimally Invasive Sensors (wearable)
Smart Device Integrated Systems (mobile app connectivity, Bluetooth)

By Consumer Type

Non-diabetic Health Enthusiasts
Pre-diabetic and At-risk Individuals
Diabetic Patients

By Application

Diabetes Management
Preventive Health and Wellness Monitoring
Fitness and Personalized Nutrition

By Distribution Channel

Pharmacies / Drugstores
Online Retailers
Supermarkets / Specialty Health Stores

By Region

North America
Europe
Asia Pacific
Latin America
Middle East
Africa

Regional Analysis:

North America: Leading Market Share with Advanced Infrastructure

The North America Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market size was valued at USD 66.05 million in 2018 to USD 135.44 million in 2024 and is anticipated to reach USD 459.86 million by 2032, at a CAGR of 15.4% during the forecast period. North America holds the largest share, comprising 34.5% of the global market in 2024. It benefits from robust healthcare infrastructure, high consumer awareness, and rapid adoption of digital health solutions. Favorable reimbursement policies, strong distribution networks, and frequent product launches by key manufacturers fuel market leadership. Major players collaborate with pharmacy chains, boosting product accessibility. The region’s emphasis on preventive health and advanced regulatory standards supports ongoing demand and continuous innovation.

Europe: Expanding Access with Regulatory Support

The Europe Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market size was valued at USD 46.75 million in 2018 to USD 93.57 million in 2024 and is anticipated to reach USD 299.00 million by 2032, at a CAGR of 14.5% during the forecast period. Europe accounts for 23.8% of the global market in 2024, propelled by rising diabetes incidence, supportive healthcare systems, and favorable regulatory frameworks for non-prescription devices. Public health campaigns and cross-border partnerships stimulate market growth. Consumers value comfort and convenience, fueling the adoption of new CGM technologies. Global and regional manufacturers maintain a competitive environment through continuous innovation and tailored service models.

Asia Pacific: Rapid Growth Driven by Large Diabetic Population

The Asia Pacific Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market size was valued at USD 32.40 million in 2018 to USD 72.46 million in 2024 and is anticipated to reach USD 276.03 million by 2032, at a CAGR of 17.1% during the forecast period. Asia Pacific represents 18.5% of the market in 2024 and demonstrates the fastest growth rate globally. The market is driven by a large diabetic population, rising healthcare spending, and accelerating urbanization across countries such as China, India, and Japan. Government-backed digital health initiatives and robust e-commerce infrastructure support widespread adoption. Manufacturers focus on affordability and innovation, delivering region-specific solutions and expanding access through online platforms.

Latin America: Rising Awareness and Improved Accessibility

The Latin America Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market size was valued at USD 6.98 million in 2018 to USD 14.29 million in 2024 and is anticipated to reach USD 42.42 million by 2032, at a CAGR of 13.5% during the forecast period. Latin America comprises 3.6% of the global market in 2024, with growth supported by increasing health awareness and gradual improvements in healthcare infrastructure. Partnerships between international device makers and local distributors enhance reach. Expanding retail pharmacy networks and digital sales channels boost product availability in both urban and rural areas. Government and NGO-led initiatives further promote diabetes management and market expansion.

Middle East: Emerging Demand Supported by Healthcare Modernization

The Middle East Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market size was valued at USD 4.45 million in 2018 to USD 8.44 million in 2024 and is anticipated to reach USD 24.12 million by 2032, at a CAGR of 12.9% during the forecast period. The region holds 2.2% of the global market in 2024, with demand shaped by rising diabetes prevalence and increasing investments in healthcare modernization. Urban centers see higher uptake, supported by private healthcare expansion and digital health campaigns. Manufacturers offer culturally relevant solutions, and collaborations with local providers accelerate access. The Middle East remains a promising market for sustained growth.

Africa: Incremental Progress Driven by Education and Partnerships

The Africa Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market size was valued at USD 1.66 million in 2018 to USD 3.98 million in 2024 and is anticipated to reach USD 9.62 million by 2032, at a CAGR of 10.5% during the forecast period. Africa accounts for 1.0% of the global market in 2024 and sees gradual growth driven by improved healthcare access and disease education. Limited resources and affordability remain challenges, but partnerships with NGOs and international agencies expand CGM reach. Local distributors focus on lower-cost solutions, while ongoing campaigns highlight the importance of diabetes monitoring. Africa’s market outlook remains positive as infrastructure and awareness initiatives progress.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis:

Abbott Laboratories
Dexcom, Inc.
Medtronic plc
Senseonics Holdings
Ascensia Diabetes Care
i-SENS, Inc.

Competitive Analysis:

The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market features intense competition among established medical device manufacturers and innovative technology firms. Leading companies such as Abbott Laboratories, Dexcom, Medtronic, and Senseonics focus on expanding product portfolios and advancing sensor technology. It encourages strategic partnerships with retail pharmacies and digital health platforms to enhance product accessibility and user engagement. Continuous investment in research and development drives improvements in accuracy, comfort, and device connectivity. New entrants and regional players compete by offering cost-effective and user-friendly solutions, targeting specific consumer segments. The market also experiences rapid product cycles and a strong emphasis on regulatory compliance. Companies differentiate through innovation, customer service, and integration with digital ecosystems, establishing a dynamic and evolving competitive environment.

Recent Developments:

In July 2025, Medtronic secured the CE Mark in Europe for the MiniMed 780G system, expanding its indications to include children as young as two years old, pregnant women, and individuals with type 2 diabetes.
In April 2025, Senseonics and Sequel Med Tech announced a partnership to create the first automated insulin delivery system using the one-year Eversense 365 CGM technology.

Market Concentration & Characteristics:

The Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market exhibits a moderate-to-high market concentration, with a few dominant multinational players controlling a significant share. It is characterized by rapid technological advancement, strong regulatory oversight, and a growing emphasis on digital integration. The market values innovation in sensor design, comfort, and non-invasive solutions, driving frequent product launches. Consumer demand for real-time monitoring and preventive health management shapes competitive strategies. Companies compete on brand reputation, distribution networks, and connectivity with mobile health platforms, reinforcing a dynamic and innovation-driven market landscape.

Report Coverage:

The research report offers an in-depth analysis based on Product Type, Technology, Consumer Type, Application, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

Companies will expand partnerships with pharmacies and e-commerce platforms to enhance OTC CGM accessibility and consumer reach.
Manufacturers will focus on developing non-invasive sensor technologies that enhance comfort while maintaining accuracy.
Integration with mobile health platforms will deepen, enabling advanced data analytics and predictive health alerts.
Regulatory frameworks will evolve to support OTC distribution, simplifying approval processes for new devices.
Personalized health management features, including AI-driven insights, will become standard components in CGM apps.
Entry of cost-effective regional players will increase competition and drive price optimization across markets.
Expansion into preventive health markets will attract pre-diabetic and wellness-oriented consumers.
Enhanced interoperability standards will enable seamless sharing between CGMs, fitness trackers, and electronic health records.
Stakeholders will prioritize continuous patient education to build trust and enhance device adoption.
Ongoing sensor miniaturization will support discreet monitoring and appeal to broader demographics.

CHAPTER NO. 1: GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2: EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3: OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

3.6 Price Trend Analysis

3.6.1 Regional Price Trend
3.6.2 Price Trend by product

CHAPTER NO. 4: KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Product Categories

4.3 Application Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Product Type & Technology Revenue

CHAPTER NO. 6: TRADE & COMMERCE ANALYSIS

6.1. Import Analysis by Region

6.1.1. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Import Volume By Region

6.2. Export Analysis by Region

6.2.1. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Export Volume By Region

CHAPTER NO. 7: COMPETITION ANALYSIS

7.1. Company Market Share Analysis

7.1.1. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market: Company Market Share

7.1. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Company Volume Market Share

7.2. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Company Revenue Market Share

7.3. Strategic Developments

7.3.1. Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8: OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – BY PRODUCT TYPE SEGMENT ANALYSIS

8.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Product Type Segment

8.1.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Product Type

8.1.2. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Product Type

8.2. Continuous Glucose Monitors

8.3. Smart Glucometers

8.4. Biosensors

8.5. Others

CHAPTER NO. 9: OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – BY TECHNOLOGY SEGMENT ANALYSIS

9.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Technology Segment

9.1.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Technology

9.1.2. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Technology

9.2. Disposable Minimally Invasive Sensors (wearable)

9.3. Smart Device Integrated Systems (mobile app connectivity, Bluetooth)

CHAPTER NO. 10: OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – BY CONSUMER TYPE SEGMENT ANALYSIS

10.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Consumer Type Segment

10.1.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Consumer Type

10.1.2. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Consumer Type

10.2. Non-diabetic Health Enthusiasts

10.3. Pre-diabetic and At-risk Individuals

10.4. Diabetic Patients

CHAPTER NO. 11: OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – BY APPLICATION SEGMENT ANALYSIS

11.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Application Segment

11.1.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Application

11.1.2. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Application

11.2. Diabetes Management

11.3. Preventive Health and Wellness Monitoring

11.4. Fitness and Personalized Nutrition

CHAPTER NO. 12: OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS

12.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Distribution Channel Segment

12.1.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Distribution Channel

12.1.2. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Distribution Channel

12.2. Pharmacies / Drugstores

12.3. Online Retailers

12.4. Supermarkets / Specialty Health Stores

CHAPTER NO. 13: OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – REGIONAL ANALYSIS

13.1. Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Region Segment

13.1.1. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Region

13.1.2. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Region

13.1.3. Regions

13.1.4. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Region

13.1.5. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Region

13.1.6. Product Type

13.1.7. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Product Type

13.1.8. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Product Type

13.1.9. Technology

13.1.10. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Technology

13.1.11. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Technology

13.1.12. Consumer Type

13.1.13. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Consumer Type

13.1.14. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Consumer Type

13.1.15. Application

13.1.16. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Application

13.1.17. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Application

13.1.18. Distribution Channel

13.1.19. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Distribution Channel

13.1.20. Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Distribution Channel

CHAPTER NO. 14: NORTH AMERICA OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – COUNTRY ANALYSIS

14.1. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Country Segment

14.1.1. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Region

14.1.2. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Region

14.2. North America

14.2.1. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Country

14.2.2. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Country

14.2.3. Product Type

14.2.4. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Product Type

14.2.5. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Product Type

14.2.6. Technology

14.2.7. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Technology

14.2.8. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Technology

14.2.9. Consumer Type

14.2.10. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Consumer Type

14.2.11. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Consumer Type

14.2.12. Application

14.2.13. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Application

14.2.14. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Application

14.2.15. Distribution Channel

14.2.16. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Distribution Channel

14.2.17. North America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Distribution Channel

14.3. U.S.

14.4. Canada

14.5. Mexico

CHAPTER NO. 15: EUROPE OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – COUNTRY ANALYSIS

15.1. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Country Segment

15.1.1. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Region

15.1.2. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Region

15.2. Europe

15.2.1. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Country

15.2.2. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Country

15.2.3. Product Type

15.2.4. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Product Type

15.2.5. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Product Type

15.2.6. Technology

15.2.7. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Technology

15.2.8. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Technology

15.2.9. Consumer Type

15.2.10. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Consumer Type

15.2.11. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Consumer Type

15.2.12. Application

15.2.13. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Application

15.2.14. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Application

15.2.15. Distribution Channel

15.2.16. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Distribution Channel

15.2.17. Europe Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Distribution Channel

15.3. UK

15.4. France

15.5. Germany

15.6. Italy

15.7. Spain

15.8. Russia

15.9. Rest of Europe

CHAPTER NO. 16: ASIA PACIFIC OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – COUNTRY ANALYSIS

16.1. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Country Segment

16.1.1. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Region

16.1.2. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Region

16.2. Asia Pacific

16.2.1. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Country

16.2.2. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Country

16.2.3. Product Type

16.2.4. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Product Type

16.2.5. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Product Type

16.2.6. Technology

16.2.7. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Technology

16.2.8. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Technology

16.2.9. Consumer Type

16.2.10. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Consumer Type

16.2.11. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Consumer Type

16.2.12. Application

16.2.13. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Application

16.2.14. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Application

16.2.15. Distribution Channel

16.2.16. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Distribution Channel

16.2.17. Asia Pacific Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Distribution Channel

16.3. China

16.4. Japan

16.5. South Korea

16.6. India

16.7. Australia

16.8. Southeast Asia

16.9. Rest of Asia Pacific

CHAPTER NO. 17: LATIN AMERICA OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – COUNTRY ANALYSIS

17.1. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Country Segment

17.1.1. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Region

17.1.2. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Region

17.2. Latin America

17.2.1. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Country

17.2.2. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Country

17.2.3. Product Type

17.2.4. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Product Type

17.2.5. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Product Type

17.2.6. Technology

17.2.7. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Technology

17.2.8. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Technology

17.2.9. Consumer Type

17.2.10. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Consumer Type

17.2.11. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Consumer Type

17.2.12. Application

17.2.13. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Application

17.2.14. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Application

17.2.15. Distribution Channel

17.2.16. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Distribution Channel

17.2.17. Latin America Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Distribution Channel

17.3. Brazil

17.4. Argentina

17.5. Rest of Latin America

CHAPTER NO. 18: MIDDLE EAST OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – COUNTRY ANALYSIS

18.1. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Country Segment

18.1.1. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Region

18.1.2. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Region

18.2. Middle East

18.2.1. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Country

18.2.2. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Country

18.2.3. Product Type

18.2.4. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Product Type

18.2.5. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Product Type

18.2.6. Technology

18.2.7. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Technology

18.2.8. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Technology

18.2.9. Consumer Type

18.2.10. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Consumer Type

18.2.11. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Consumer Type

18.2.12. Application

18.2.13. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Application

18.2.14. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Application

18.2.15. Distribution Channel

18.2.16. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Distribution Channel

18.2.17. Middle East Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Distribution Channel

18.3. GCC Countries

18.4. Israel

18.5. Turkey

18.6. Rest of Middle East

CHAPTER NO. 19: AFRICA OVER-THE-COUNTER (OTC) CONTINUOUS GLUCOSE MONITORS (CGMS) MARKET – COUNTRY ANALYSIS

19.1. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Overview by Country Segment

19.1.1. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume Share By Region

19.1.2. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue Share By Region

19.2. Africa

19.2.1. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Country

19.2.2. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Country

19.2.3. Product Type

19.2.4. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Product Type

19.2.5. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Product Type

19.2.6. Technology

19.2.7. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Technology

19.2.8. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Technology

19.2.9. Consumer Type

19.2.10. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Consumer Type

19.2.11. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Consumer Type

19.2.12. Application

19.2.13. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Application

19.2.14. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Application

19.2.15. Distribution Channel

19.2.16. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Volume By Distribution Channel

19.2.17. Africa Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market Revenue By Distribution Channel

19.3. South Africa

19.4. Egypt

19.5. Rest of Africa

CHAPTER NO. 20: COMPANY PROFILES

20.1. Abbott Laboratories

20.1.1. Company Overview

20.1.2. Product Portfolio

20.1.3. Financial Overview

20.1.4. Recent Developments

20.1.5. Growth Strategy

20.1.6. SWOT Analysis

20.2. Dexcom, Inc.

20.3. Medtronic plc

20.4. Senseonics Holdings

20.5. Ascensia Diabetes Care

20.6. i-SENS, Inc.

20.7. Company 7

20.8. Company 8

20.9. Company 9

20.10. Company 10

Frequently Asked Questions

What is the current size of the Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market?

The market size reached USD 328.17 million in 2024 and is projected to grow to USD 1,111.05 million by 2032.

What factors are driving the growth of the Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market?

Growth is driven by rising diabetes prevalence, adoption of digital health tools, sensor technology innovations, and greater health awareness.

What are the key segments within the Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market?

Key segments include product type, technology, consumer type, application, and distribution channel.

What are some challenges faced by the Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market?

Challenges include complex regulatory requirements, product reliability concerns, and limited awareness in certain regions.

Who are the major players in the Global Over-The-Counter (OTC) Continuous Glucose Monitors (CGMs) Market?

Major players include Abbott Laboratories, Dexcom, Medtronic, Senseonics, Ascensia Diabetes Care, and i-SENS.

Which segment is leading the market share?

Continuous glucose monitors are leading the market share by product type.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Reviewed By
Gunakesh Parmar

Research Consultant

With over 15 years of dedicated experience in market research since 2009, specializes in delivering actionable insights from data.

View Profile

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$12699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –